Source comparison
Comparison: CJC-1295 with DAC vs. CJC-1295 without DAC — Safety Profile Differences
Plasma half-life (rat) ~6-8 days ~30 minutes Injection site reactions Mild, transient in subset Minimal reported GH pulse pattern Sustained elevation, blunted pulsatility Acute pulse preserved IGF-1 elevation duration 7-14 days per dose Hours per dose Immunoge
This comparison does not assign a generated winner or score.
- Plasma half-life (rat)
- ~6-8 days
- ~30 minutes
- Injection site reactions
- Mild, transient in subset
- Minimal reported
- GH pulse pattern
- Sustained elevation, blunted pulsatility
- Acute pulse preserved
- IGF-1 elevation duration
- 7-14 days per dose
- Hours per dose
- Immunogenicity potential
- Low; hapten concern theoretical
- Very low
- Organomegaly risk (supratherapeutic)
- Reported at high doses, reversible
- Not reported in published data
- Washout period needed
- Minimum 2-3 weeks recommended
- 24-48 hours adequate
- Dosing frequency for sustained effect
- Once weekly in rodents
- Daily or twice daily